Drugs News and Research

RSS

Apathy and depression, separate issues in Parkinson's disease

According to researchers in the U.S. people suffering from Parkinson's disease can be apathetic without being depressed, and apathy may be a core feature of the disease.

17 Jul 2006

New hope for ways to overcome drug resistance in lung cancer

Scientists have suggested it may be possible to reverse drug resistance in lung cancer patients, thereby improving the effectiveness of chemotherapy, according to research published in the EMBO Journal.

13 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

Researchers discover two-way communication and stimulation between blood stem cells and T cells

When a transplant patient suffers complications such as graft rejection or graft-versus-host disease, physicians attempt to stop the body's immune response by targeting a patient's T cells.

13 Jul 2006

Mechanics of atherosclerosis

Atherosclerotic narrowing and hardening of coronary arteries typically appear first at vessel branches, and a study in the October issue of Cellular Signalling reports that the type of mechanical stretching found at those branches activates a cellular protein known to damage cells.

12 Jul 2006

NIAID program aims to model immune responses and key infectious diseases

A new program at the National Institute of Allergy and Infectious Diseases (NIAID) aims to better understand the complex biochemical networks that regulate the interactions between infectious organisms and the human or animal cells they infect.

12 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Morning sickness - a form of protection for mother and baby

As many as 90% of mothers experience nausea during pregnancy, and about half that number vomit.

12 Jul 2006

Children with chronic otitis media have biofilms in their middle ears

Direct evidence of bacterial biofilms has been found on the middle ear tissue of children who suffer from chronic ear infections

12 Jul 2006

Allergy battle could be won in five years

Allergies such as asthma, eczema and hay fever could be snuffed out within five years thanks to pioneering work at The University of Manchester.

From The University of Manchester 12 Jul 2006

3D model reveals secrets of metastasis

A cancer cell breaks away from a primary tumor and settles in a new location, where it once again divides.

12 Jul 2006

"Magic" mushrooms create profound mystical experience and change behaviour

A group of healthy well educated volunteers appear to have achieved some sort of profound mystical experience that led to behaviour changes lasting for weeks after taking a drug derived from 'magic mushrooms'.

12 Jul 2006

New study sets out to find why people don't donate organs

Researchers are looking for volunteers to take part in a new study to find out why there is a shortage of organ donations in the UK.

12 Jul 2006

Vioxx user was a heart attack waiting to happen

In the on-going court battle facing drug company Merck over it's blockbuster painkiller Vioxx, a lawyer for Merck has said one of the plaintiffs was more or less a heart attack waiting to happen regardless of Vioxx.

12 Jul 2006

Study shows high survival for patients with torn aortas who get surgery

Nearly three years ago, actor John Ritter collapsed on the set of his sitcom, the victim of a rare but often deadly condition called aortic dissection - a tear in the largest blood vessel in the body.

11 Jul 2006

Roswell Park research aids development of myeloma drug

Roswell Park Cancer Institute (RPCI) researchers played a leading role in clinical studies which led to U.S. Food and Drug Administration (FDA) approval of a new treatment for patients diagnosed with multiple myeloma - the second most common blood cancer.

11 Jul 2006

Hallucinogen in mushrooms creates mystical/spiritual experiences

Using unusually rigorous scientific conditions and measures, Johns Hopkins researchers have shown that the active agent in "sacred mushrooms" can induce mystical/spiritual experiences descriptively identical to spontaneous ones people have reported for centuries.

11 Jul 2006